Glioblastoma Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Glioblastoma Market is segmented By Glioblastoma Epidemiology (Total Incident Cases of Glioblastoma, Gender-specific Incidence, Type-specific Incidence, Age-specific Inci ....

Glioblastoma Market Size

Market Size in USD

CAGR13.1%

Study Period2024 - 2031
Base Year of Estimation2023
CAGR13.1%
Market ConcentrationHigh
Major PlayersBayer, Chimerix, Aivita Biomedical, Denovo Biopharma, Northwest Therapeutics
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
setting-icon
Want to purchase customized report?
please let us know !

Glioblastoma Market Analysis

The glioblastoma market is estimated to be valued at USD 1.15 Bn in 2024 and is expected to reach USD 2.74 Bn by 2031, growing at a compound annual growth rate (CAGR) of 13.1% from 2024 to 2031. With growing geriatric population and rising incidence rates of brain cancer, the market is poised to witness significant growth over the forecast period.

The market is driven by rising research into innovative treatment options and increasing approval of pipeline drugs. Major pharmaceutical players have ramped up R&D investments to develop targeted therapies and immunotherapies to treat Glioblastoma. Furthermore, growing awareness about the disease and better diagnosis is also contributing to the market growth. However, high cost of treatment continues to hinder widespread adoption.